Clinical Trial Update: TAHOE: Intravitreal Dexamethasone Implant (Ozurdex) for Uveitic Macular Edema [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on using intravitreal dexamethasone implant (Ozurdex) for uveitic macular edema; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Edema
• Uveitis

Drugs mentioned

• Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: Northern California Retina Vitreous Associates | Conditions: Macular Edema, Uveitis | Phase 4 | Status: COMPLETED